title: Stability, denaturation and refolding of Mycobacterium tuberculosis MfpA, a DNA mimicking protein that confers antibiotic resistance.
abstract: MfpA from Mycobacterium tuberculosis is a founding member of the pentapeptide repeat class of proteins (PRP) that is believed to confer bacterial resistance to the drug fluoroquinolone by mimicking the size, shape and surface charge of duplex DNA. We show that phenylalanine side chain stacking stabilizes the N-terminus of MfpA's pentapeptide thus extending the DNA mimicry analogy. The Lumry-Eyring model was applied to multiple spectral measures of MfpA denaturation revealing that the MfpA dimer dissociates to monomers which undergo a structural transition that leads to aggregation. MfpA retains high secondary and tertiary structure content under denaturing conditions. Dimerization stabilizes MfpA's pentapeptide repeat fold. The high Arrhenius activation energy of the barrier to aggregate formation rationalizes its stability. The mechanism of MfpA denaturation and refolding is a 'double funnel' energy landscape where the 'native' and 'aggregate' funnels are separated by the high barrier that is not overcome during in vitro refolding.
authors: Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA. khraps@einstein.yu.edu
authors: Sergei
authors: S
authors: Khrapunov
authors: Michael
authors: M
authors: Brenowitz
references: Biophys J. 2007 May 15;92(10):3674-85
references: 17351005
references: Biophys Chem. 2007 Sep;129(2-3):251-8
references: 17618035
references: J Biol Chem. 2008 Dec 26;283(52):36290-9
references: 18977756
references: Trends Microbiol. 1997 Mar;5(3):102-9
references: 9080608
references: Trends Biochem Sci. 2007 May;32(5):217-24
references: 17412596
references: Science. 2002 Feb 1;295(5556):851-5
references: 11823641
references: Nat Rev Drug Discov. 2008 Dec;7(12):1013-30
references: 19043451
references: Biochim Biophys Acta. 2002 Jan 31;1594(1):168-77
references: 11825619
references: Adv Protein Chem. 1995;47:83-229
references: 8561052
references: Appl Environ Microbiol. 2009 Jun;75(12):4101-10
references: 19395568
references: Annu Rev Biochem. 2006;75:333-66
references: 16756495
references: Biochim Biophys Acta. 2005 Aug 10;1751(2):119-39
references: 16027053
references: Methods Enzymol. 1999;309:48-58
references: 10507015
references: Biochemistry. 1997 May 13;36(19):5884-92
references: 9153430
references: Biochim Biophys Acta. 2005 Oct 1;1716(1):59-68
references: 16168383
references: Biophys J. 1992 Apr;61(4):921-35
references: 19431826
references: Biochemistry. 2006 Dec 12;45(49):14559-66
references: 17144649
references: Annu Rev Biophys Biophys Chem. 1989;18:47-69
references: 2660833
references: Methods Enzymol. 1986;131:266-80
references: 3773761
references: Int J Biol Macromol. 1993 Dec;15(6):337-41
references: 8110654
references: Biochemistry. 1971 Mar 2;10(5):743-52
references: 5544664
references: Biochim Biophys Acta. 1997 Mar 20;1351(1-2):213-22
references: 9116035
references: Biochemistry. 2006 Jan 10;45(1):1-10
references: 16388575
references: Trends Biochem Sci. 2004 Oct;29(10):527-34
references: 15450607
references: Nat Rev Mol Cell Biol. 2002 Jun;3(6):430-40
references: 12042765
references: Science. 2001 Jul 20;293(5529):487-9
references: 11463915
references: Science. 2005 Jun 3;308(5727):1480-3
references: 15933203
references: Anal Biochem. 2009 Jun 15;389(2):174-6
references: 19332020
references: Proteins. 2000;Suppl 4:1-7
references: 11013396
references: FEBS Lett. 2007 Feb 6;581(3):375-81
references: 17222408
references: Methods Enzymol. 2004;383:318-51
references: 15063656
references: Biophys J. 1994 Feb;66(2 Pt 1):482-501
references: 8161701
references: Biochemistry. 1999 Aug 17;38(33):10814-22
references: 10451378
references: Biochem Soc Trans. 2006 Apr;34(Pt 2):317-9
references: 16545103
references: Biochemistry. 1988 Oct 18;27(21):8063-8
references: 3233195
references: Philos Trans A Math Phys Eng Sci. 2005 Feb 15;363(1827):453-64; discussion 464-7
references: 15664893